ZP Therapeutics, a division of Zuellig Pharma, has announced an official agreement with the Government Pharmaceutical Organization (GPO) to supply and distribute five million doses of the COVID-19 Vaccine Moderna in Thailand from the fourth quarter (Q4) of 2021.

The two organisations will work closely with the Private Hospital Association (PHA) to expand access to alternative vaccines and secure supplies beyond the initial purchase, so as to accelerate the country’s COVID-19 vaccination programme and overcome the COVID-19 pandemic.

Dr. Withoon Danwiboon, Managing Director, Government Pharmaceutical Organization, said, "We play a key role in providing more vaccine options under Emergency Use Authorization (EUA) to combat the ongoing pandemic. We will coordinate with the government, the Private Hospital Association, and ZP Therapeutics to secure the supply of the COVID-19 Vaccine Moderna into 2022."

Pucknalin Bulakul, Chief Executive of Zuellig Pharma Thailand, said, "Zuellig Pharma Thailand’s global standard warehouses and cold chain capacity of more than 40,000 sqm are equipped to store and distribute large quantities of COVID-19 Vaccine Moderna."